ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards
In Brief: Fidler Wins BMS Cancer Research Award; Thomas Cech To Head Howard Hughs Inst.
Capitol Hill: Bills Seeks Coverage for Treatment Of cancers Found in CDC Screening
Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says
Science Policy: NI DOD Begins Project For Common Coding Of Cancer Grants
In Brief: Ahoy! It’s “Admiral Rick”
Professional Societies: AACR Awards Honor 8 Scientists, Clinicians
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
